Little Green Pharma Ltd
Little Green Pharma to Divest WA Production Site in $7.8 Million Sale and Lease-Back Deal
LGP to sell WA production site for $7.8m in a sale-and-lease-back to fund Australian and European expansion; settlement targeted mid-March 2026.
Trump’s CBD Comments Ignite US Cannabis Stocks Surge – Will ASX Companies Follow Suit?
Shares of cannabis and CBD-related companies surged on Monday after US President Donald Trump posted on Truth Social that hemp-derived cannabidiol (CBD), especially in senior healthcare, “could revolutionize” treatment by reducing disease progression and providing an alternative to prescription drugs. He further reiterated his administration is exploring reclassifying marijuana under federal law, a change that could […]
Little Green Pharma takes delivery of first cannabis flower shipment from new Danish growing facility
Perth-based medicinal cannabis producer Little Green Pharma (ASX: LGP) has taken delivery of the first shipment of cannabis flower medicines from its new growing facility in Denmark. The company imported approximately 50 kilograms of “Billy Buttons” THC (tetrahydrocannabinol) flower, approximately two months after finalising the $21.4 million acquisition. Named after an Australian wildflower, the medicine […]
Little Green Pharma grows full-year profits to record $24.6m
Australian medicinal cannabis producer Little Green Pharma (ASX: LGP) has recorded a healthy FY 2021 performance, generating over $7 million in revenue to 30 June and banking a record profit after tax of $24.6 million. The company’s revenue from ordinary activities exceeded the previous year’s loss of $9.3 million and included gains on the $24.9 […]